title: Changes in the template activity of chromatin isolated from sarcoma-180 ascites cells treated with mitomycin C and gamma irradiation in vivo.
abstract: The murine ascites sarcoma 180 cells were used to test the in vivo effectiveness of mitomycin C (MMC) and gamma-radiation applied in combination. The action of intraperitoneal administration of MMC and/or whole-body gamma irradiation on sarcoma 180 tumor bearing Swiss albino mice was investigated by studying the template activity of isolated tumor chromatin. The Km value for transcription of 10 Gy-irradiated chromatin was found to decrease with time implying an increase in the template efficiency with respect to that of the unirradiated control. Maximum decrease in Km was observed after 24 h of irradiation. MMC treatment (7 mg/kg body weight of mouse) for 18 h resulted in an inhibition of the transcription rate. Severe inhibition in the template activity was found when cells were subjected to MMC treatment 18 h prior to irradiation with 10 Gy. Susceptibility of tumor chromatin to DNase II followed the same pattern as observed in the case of transcription indicating structural alteration of the treated chromatin. The data showed that DNA damage and its consequences produced in the ascites cells by prior treatment of MMC were not repaired during the 18 h period after which the application of radiation enhanced cytotoxicity.
authors.affiliation: Department of Biophysics, Chittaranjan National Cancer Research Centre, Calcutta, India.
authors.forename: A
authors.initials: A
authors.lastname: Karuri
authors.forename: S
authors.initials: S
authors.lastname: Mukherji
mesh_terms: D000818:Animals; D002455:Cell Division / Q000187:drug effects / Q000528:radiation effects; D002460:Cell Line; D002843:Chromatin / Q000302:isolation & purification*; D003131:Combined Modality Therapy; D004249:DNA Damage; D004706:Endodeoxyribonucleases / Q000528:radiation effects; D007700:Kinetics; D051379:Mice; D016685:Mitomycin; D008937:Mitomycins / Q000494:pharmacology* / Q000627:therapeutic use; D012510:Sarcoma 180 / Q000188:drug therapy / Q000235:genetics* / Q000532:radiotherapy; D013698:Templates, Genetic / Q000187:drug effects / Q000528:radiation effects; D013997:Time Factors; D014158:Transcription, Genetic
chemical_list: D002843:Chromatin; D008937:Mitomycins; D016685:Mitomycin; D004706:Endodeoxyribonucleases; C019329:deoxyribonuclease II